Exchange: NASDAQ·Updated 07:30 PM EDT

BRVE Braveheart Bio Inc.

$21.87
$0.43
(2.01%)
Today
Closed $21.87
$0.00
(0.00%)
After Hours
EarningsNov 12
Mkt Cap$1.97B
Vol101,221.00

About BRVE

Braveheart Bio, Inc. engages in the development of therapeutics to treat hypertrophic cardiomyopathy. Its lead product candidate is BHB-1839 which is a small-molecule cardiac myosin inhibitor. The company was founded on May 13,2024 and is headquartered in San Francisco, CA.
39

Bearish Sentiment

How do you feel about BRVE?

Advertisement|Remove ads.